Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Comparing two techniques for harvesting the left internal thoracic artery in heart surgery

Official title: Randomized Comparison of HARVesting the Left Internal Thoracic Artery in a Skeletonized Versus Pedicled Technique: the HARVITA Trial

Run by Medical University Innsbruck · NCT05931783 · Data updated 2026-11-12

This study is testing whether two different ways of taking the left internal thoracic artery for heart surgery can lead to better recovery and survival for people having coronary artery bypass surgery.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment1350 (estimated)
SponsorMedical University Innsbruck
Academic / other
Drugs / interventionsradiation
Locations8 sites (Graz and 7 other locations)
StatusRecruiting
StartedMarch 12, 2024
Main results expectedOctober 1, 2028
Study endsOctober 1, 2031
Registry record updatedMarch 15, 2024
Trial IDNCT05931783 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are primary isolated CABG patients with multi-vessel disease.

Probably not a fit

Patients over 80 years old or those requiring CABG without the use of LITA will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the impact of two different techniques for harvesting the left internal thoracic artery (LITA) on graft patency rates and patient survival in individuals undergoing coronary artery bypass grafting (CABG). The study is a prospective, randomized, multi-centre trial that aims to determine whether the skeletonized or pedicled harvesting technique yields better clinical outcomes. By comparing these techniques, the trial seeks to provide evidence that could influence surgical practices and improve patient care in coronary artery disease. Participants will be carefully selected based on specific inclusion and exclusion criteria to ensure the validity of the results.

Why it matters

Potential benefit: If successful, this study could lead to improved graft patency rates and better survival outcomes for patients undergoing CABG.

How similar studies have gone: Other studies have explored similar harvesting techniques, but this trial aims to provide more definitive evidence on their comparative effectiveness.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

Primary isolated CABG patients with multi-vessel disease (defined as ≥70 % stenosis of the left anterior descending artery (LAD) and ≥50% stenosis of circumflex and right coronary territory, with or without a ≥50% stenosis of the left main artery).

Exclusion criteria:

* Age \> 80 years
* Planned CABG without LITA use
* Preoperative mediastinal radiation therapy
* Emergency operation
* Minimal invasive coronary artery bypass surgery
* Any concomitant cardiac or non-cardiac procedures
* Previous cardiac surgery
* Known contrast agent allergy
* Severe stenosis of the left subclavian artery/ left-sided subclavian steal syndrome
* Chronic kidney disease (GFR \<60ml/min/1.73m²)
* Life expectancy of less than 5 years
* Pregnancy
* Hyperthyroidism
* Iodine allergy

Intraoperative exclusion criteria:

* Y/T graft off the LITA graft
* LITA sequential grafting
* LITA target vessel other than LAD

Where it's running

  • Medical University of Innsbruck
    Innsbruck, Austria
    Recruiting
  • Medical University of Graz
    Graz, Austria
    Not yet recruiting
  • Medical University of Vienna
    Vienna, Austria
    Not yet recruiting
  • University of Duisburg-Essen
    Essen, Germany
    Not yet recruiting
  • University of Freiburg
    Freiburg im Breisgau, Germany
    Not yet recruiting
  • University Hospital Gießen
    Giessen, Germany
    Not yet recruiting
Show 2 more locations
  • University of Jena
    Jena, Germany
    Not yet recruiting
  • University Hospital Bern
    Bern, Switzerland
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.